Phase 2 Plexiform Neurofibroma Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Neurofibromatosis 1Plexiform Neurofibroma

University of Alabama at Birmingham200 enrolled13 locationsNCT06188741

Recruiting

Phase 2

HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Neurofibromatosis 1Plexiform Neurofibromas

Shanghai Kechow Pharma, Inc.70 enrolled1 locationNCT05331105

Active

Phase 2

TiNT: Trametinib in Neurofibromatosis type 1 associated tumours

Optic pathway gliomaPlexiform neurofibromatosis

Australian and New Zealand Children's Haematology/Oncology Group120 enrolled11 locationsACTRN12620001229965